CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
KRT8 |
P05787
|
keratin 8
|
|
2.4E-08 |
0.517 |
0.654 |
MTX1 |
Q13505
|
metaxin 1
|
|
1.3E-02 |
0.546 |
0.731 |
PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
FRY |
Q5TBA9
|
FRY microtubule binding protein
|
|
1.00 |
0.666 |
0.500 |
RALY |
Q9UKM9
|
RALY heterogeneous nuclear ribonucleoprotein
|
|
0.14 |
0.656 |
0.385 |
BABAM1 |
Q9NWV8
|
BRISC and BRCA1 A complex member 1
|
|
0.96 |
0.678 |
0.385 |
USHBP1 |
Q8N6Y0
|
USH1 protein network component harmonin binding protein 1
|
|
3.0E-17 |
0.705 |
0.269 |
BTBD9 |
Q96Q07
|
BTB domain containing 9
|
|
7.1E-09 |
0.691 |
0.423 |
CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
TUBA1C |
Q9BQE3
|
tubulin alpha 1c
|
Cellular structure
|
7.4E-03 |
0.663 |
0.577 |
PTEN |
P60484
|
phosphatase and tensin homolog
|
Enzyme
|
0.26 |
0.305 |
0.923 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
FBXW7 |
Q969H0
|
F-box and WD repeat domain containing 7
|
Enzyme modulator
|
1.00 |
0.465 |
0.808 |
B2M |
P61769
|
beta-2-microglobulin
|
Immune response
|
0.56 |
0.447 |
0.846 |
KCNH1 |
O95259
|
potassium voltage-gated channel subfamily H member 1
|
Ion channel
|
0.55 |
0.542 |
0.731 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
FGFR2 |
P21802
|
fibroblast growth factor receptor 2
|
Kinase
|
1.00 |
0.380 |
0.808 |